Amgen Can't Amend Petition To Address Potential Double Tax
By Molly Moses · June 10, 2026, 4:45 PM EDT
Drugmaker Amgen isn't entitled to amend its petition to protect against possible double taxation after an eight-week trial and briefing in its income-allocation case already have been completed, the U.S. Tax Court...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login
